Retatrutide
10mg vial
Triple-action GLP-1/GIP/Glucagon receptor agonist. Studied for metabolic optimization and appetite regulation.
Find compounds by name, research topic, or area of interest.
10mg vial
Triple-action GLP-1/GIP/Glucagon receptor agonist. Studied for metabolic optimization and appetite regulation.
20mg vial
Triple-action GLP-1/GIP/Glucagon receptor agonist. Large research vial for extended protocols.
30mg vial
Triple-action GLP-1/GIP/Glucagon receptor agonist. Large 30mg research vial for extended metabolic protocols.
60mg vial
Retatrutide 20mg + Tirzepatide 40mg in one 60mg vial for combined incretin and metabolic research.
30mg vial
Dual GIP/GLP-1 receptor agonist. Studied for insulin secretion, appetite regulation, and metabolic optimization.
10mg vial
GHRH analogue. Studied for GH secretion, visceral adipose reduction, and metabolic function.
20mg vial
GHRH analogue. Large 20mg research vial for extended GH secretion and metabolic studies.
10mg vial
Mitochondria-derived peptide. 10mg vial for metabolic regulation, exercise performance, and insulin sensitivity studies.
40mg vial
Mitochondria-derived peptide. Studied for metabolic regulation, exercise performance, and insulin sensitivity.
10mg vial
Modified GH fragment. 10mg vial for fat metabolism, lipolysis stimulation, and metabolic support studies.
5mg vial
Modified GH fragment. 5mg vial for fat metabolism, lipolysis stimulation, and metabolic support studies.
50mg vial
NNMT inhibitor. Studied for adipogenesis inhibition, energy expenditure, and metabolic reprogramming.
10mg vial
ERRα/ERRγ agonist. Studied as an exercise mimetic for mitochondrial biogenesis, endurance metabolism, and metabolic reprogramming.
80mg vial
Proprietary longevity research blend. 80mg formulation studied for metabolic and cellular aging pathways.
1000mg vial
Nicotinamide adenine dinucleotide. Studied for mitochondrial function, DNA repair, and anti-aging mechanisms.
1500mg vial
Reduced glutathione (GSH). Master cellular antioxidant studied for oxidative stress reduction, detoxification, and immune support.
10mg vial
KISS1-derived neuropeptide. Studied for GnRH pulse regulation, reproductive hormone axis research, and metabolic signalling.
10mg vial
Bremelanotide. Melanocortin receptor agonist studied for arousal pathway signalling and autonomic nervous system modulation.
10mg vial
Circadian rhythm hormone. Studied for sleep-wake regulation and antioxidant signalling.
10mg vial
Circadian rhythm hormone. Studied for sleep-wake regulation and antioxidant signalling.
Retatrutide activates GLP-1, GIP, and glucagon receptors simultaneously. Here's what the Phase 2 trial data shows and why researchers are paying close attention.